Clinical application of antibody immunity against SARS-CoV-2: Comprehensive review on immunoassay and immunotherapy

ZJ Cheng, B Li, Z Zhan, Z Zhao, M Xue, P Zheng… - Clinical Reviews in …, 2022 - Springer
The current COVID-19 global pandemic poses immense challenges to global health, largely
due to the difficulty to detect infection in the early stages of the disease, as well as the …

[HTML][HTML] Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a …

D Buonfrate, C Piubelli, F Gobbi, D Martini… - Clinical Microbiology …, 2021 - Elsevier
Objectives To assess the antibody response to BNT162b2 mRNA COVID-19 vaccine in a
cohort of health-care workers (HCW), comparing individuals with previous severe acute …

The serological sciences network (SeroNet) for COVID-19: depth and breadth of serology assays and plans for assay harmonization

AB Karger, JD Brien, JM Christen, S Dhakal, TJ Kemp… - MSphere, 2022 - Am Soc Microbiol
ABSTRACT In October 2020, the National Cancer Institute (NCI) Serological Sciences
Network (SeroNet) was established to study the immune response to COVID-19, and “to …

Development of a cell-based SARS-CoV-2 pseudovirus neutralization assay using imaging and flow cytometry analysis

JR Izac, EJ Kwee, L Tian, E Elsheikh… - International Journal of …, 2023 - mdpi.com
COVID-19 is an ongoing, global pandemic caused by the novel, highly infectious SARS-CoV-
2 virus. Efforts to mitigate the effects of SARS-CoV-2, such as mass vaccination and …

Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2

G Malipiero, P D'Agaro, L Segat, A Moratto… - Clinica Chimica Acta, 2022 - Elsevier
Background and aims Long-term kinetics of anti-RBD IgG and neutralizing antibodies were
analyzed in a cohort of COVID-19 naïve health care workers (HCW) undergoing SARS-CoV …

Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study

V Petrović, V Vuković, A Patić, M Marković, M Ristić - Vaccines, 2022 - mdpi.com
Many available SARS-CoV-2 vaccines demonstrated good humoral response, but studies
directly comparing their immunogenicity in the general population are lacking. We evaluated …

Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection

L Wang, PN Patrone, AJ Kearsley, JR Izac… - International Journal of …, 2023 - mdpi.com
COVID-19 has highlighted challenges in the measurement quality and comparability of
serological binding and neutralization assays. Due to many different assay formats and …

Antibody response after two doses of homologous or heterologous SARS‐CoV‐2 vaccines in healthcare workers at health promotion centers: A prospective …

EH Nah, S Cho, H Park, S Kim, D Noh… - Journal of Medical …, 2022 - Wiley Online Library
Assaying of anti‐spike‐protein receptor‐binding domain (S‐RBD) antibodies are used to aid
evaluations of the immune statuses of individuals. The aim of this study was to determine the …

Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran

R Jafarzadeh Esfehani, Z Vahidi, M Shariati… - Journal of …, 2023 - Springer
The effectiveness of COVID-19 vaccination is still unclear in individuals with underlying
diseases such as HTLV-1 infection. This retrospective cohort study aimed to evaluate the …

Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry

G Martos, M Bedu, RD Josephs, S Westwood… - Analytical and …, 2024 - Springer
The availability of serology assays to measure antibodies against the SARS coronavirus 2
(SARS-CoV-2) expanded rapidly during the Covid-19 pandemic. The interchangeable use …